Welcome to our dedicated page for Perceptive Capital Solutions SEC filings (Ticker: PCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Perceptive Capital Solutions's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Perceptive Capital Solutions's regulatory disclosures and financial reporting.
Perceptive Capital Solutions Holdings, a former 10% owner of Freenome, Inc., reported the conversion of 2,066,250 Class B Ordinary Shares into the same number of shares of Common Stock on July 20, 2026 in connection with Freenome's business combination with Old Freenome. Following the one-for-one conversions, the reporting person holds 2,352,500 shares of Common Stock directly, and its two directors, Adam Stone and Michael Altman, share voting and investment discretion over these securities. The transactions were not executed under a Rule 10b5-1 trading plan.
Perceptive Advisors LLC, together with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., reports beneficial ownership of Freenome, Inc. Common Stock on a Schedule 13G. The Master Fund directly holds 10,871,847 shares of Common Stock, and each Reporting Person may be deemed to beneficially own these shares.
The ownership represents 10.1% of Freenome’s Common Stock, based on 107,446,814 shares outstanding as of July 20, 2026 as reported by the issuer. Each Reporting Person has 0 shares with sole voting or dispositive power and 10,871,847 shares with shared voting and shared dispositive power.
Freenome, Inc. reported that Perceptive Life Sciences Master Fund Ltd. acquired 5,500,000 shares of Common Stock on July 20, 2026 at $10.00 per share, in a grant/award-type acquisition. Following this transaction, the Master Fund’s reported Common Stock holdings total 10,871,847 shares. The securities are directly held by the Master Fund; Perceptive Advisors LLC, as investment manager, and Joseph Edelman, as managing member of the Advisor, report indirect pecuniary interests and each disclaims beneficial ownership beyond that. The Rule 10b5-1 trading plan checkbox was not marked for this transaction.
Freenome, Inc. reports that Perceptive Life Sciences Master Fund Ltd, Perceptive Advisors LLC and Joseph Edelman have filed an initial statement of beneficial ownership as 10% owners. The common stock reported corresponds to Legacy Freenome Series B, C, D and F preferred shares on an as-converted basis in connection with a business combination between Freenome Holdings, Inc. and Perceptive Capital Solutions Corp. under a Business Combination Agreement dated December 5, 2025. Perceptive Advisors and Mr. Edelman disclaim beneficial ownership beyond their indirect pecuniary interest.
Freenome, Inc. reported that former director Mark C. McKenna converted 30,000 Class B Ordinary Shares into 30,000 shares of Common Stock on July 20, 2026, in connection with the closing of its Business Combination under the Business Combination Agreement dated December 5, 2025 and amended July 20, 2026.
Freenome, Inc. reported that Perceptive Capital Solutions Holdings (the Sponsor) converted 2,066,250 Class B Ordinary Shares into the same number of shares of Common Stock on July 20, 2026 in connection with the closing of its business combination with Freenome Holdings, Inc.
The securities are held indirectly by the Sponsor, whose board, including Adam Stone and Michael Altman, has voting and investment discretion, resulting in 2,352,500 shares of Common Stock held indirectly after the conversion.
Freenome, Inc. reported that on July 20, 2026, in connection with the closing of its business combination with Freenome Holdings, Inc., Perceptive Capital Solutions Holdings, an entity whose board includes Michael Altman, converted 2,066,250 Class B Ordinary Shares into 2,066,250 shares of Common Stock. Following this one-for-one share-class conversion, Perceptive Capital Solutions Holdings indirectly held 2,352,500 shares of Common Stock.
RA Capital Management, L.P., together with Peter Kolchinsky, Rajeev Shah and affiliated funds, beneficially owns 15,367,270 shares of Freenome, Inc. common stock, representing 14.3% of the 107,446,814 shares outstanding as of the July 20, 2026 business combination closing.
The stake is held across RA Capital Healthcare Fund, L.P. (12,230,122 shares), several Nexus funds and a managed account. The investors received Freenome shares in the business combination for an aggregate prior equity investment of $218,999,969 and purchased additional PIPE shares for $52,553,760 at $10 per share. An investor rights agreement provides resale registration, demand and piggyback rights, while a lock-up restricts transfers for six months after closing. The position is for investment purposes, though the investors may adjust holdings and engage with management, and Kolchinsky serves as a director.
RA Capital Management, L.P. and affiliated investment funds reported indirect acquisitions of Freenome, Inc. common stock on July 20, 2026. Several blocks, including 6,561,711 shares, were received pursuant to a Business Combination with Old Freenome, while others, such as 4,918,411 shares, were acquired at $10.00 per share. The shares are held by RA Capital Healthcare Fund, the Nexus funds, and a separately managed account, with RA Capital as investment manager; Dr. Peter Kolchinsky and Mr. Rajeev Shah disclaim beneficial ownership beyond their respective pecuniary interests.
RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Dr. Peter Kolchinsky and Mr. Rajeev Shah report indirect ownership of 750,000 shares of Freenome, Inc. common stock, held directly by the Fund as of July 20, 2026.
The Adviser acts as investment manager to the Fund, whose general partner is RA Capital Management GP, LLC. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership except to the extent of respective pecuniary interests.